The award was due to be presented at the association's annual shindig in March, which was cancelled due to the coronavirus pandemic.
VMA Awards chair, Claire Edmunds, said: “This years’ winners will still get their moment of glory on stage next March at the rescheduled event. We can also announce that the event is likely to include some additional categories to recognise campaigns and initiatives undertaken during the COVID-19 pandemic.”
Carlos Michelsen, managing director of award sponsor, CM Research, added: "Thanks to the continued success of Cytopoint, Zoetis achieved highly commended status. But it was Elanco that came in as award winners, with their novel veterinary pharmaceutical product Galliprant taking the crown. Congratulations to Elanco!"
Rebecca Bryant, Elanco’s marketing manager for Pet Health Therapeutics (pictured right), said “Elanco is delighted to be recognised by the veterinary community with this prestigious award for Galliprant. The UK team is proud to be part of the launch of this innovative, first-in-class product which has already enriched the lives of thousands of pet owners and their dogs living with osteoarthritis. It’s fantastic to hear from vets that managing OA with Galliprant has already made a positive impact on their practices.”
Zoetis product manager, Allison Henry said: “We are very proud to come such close second in this award category as it is a true testament to the lasting innovation Cytopoint has brought to our industry, customers and pets. At Zoetis, we always strive to develop innovative new medicines for the veterinary industry and we are thrilled to see how Cytopoint has done just that.”
Sally Linghorn, Senior RVN at CVS and one of the team behind the initiative, said: “As far as we know, no other veterinary company has policy, support and specific training and guidance on this topic, in our female-biased profession.”
“We recognise how devastating pregnancy loss can be.
"Last year we launched a policy to provide special paid leave for pregnancy loss.
"But since implementing this we have noticed a gap.
"We felt our managers needed guidance and support on how to provide the more practical and emotional support on a day-to-day basis, if someone in their team experienced a loss."
The new guidance contains advice on how to understand each individual’s experiences and needs, help in the immediate situation of pregnancy loss at work, treat and record any time off directly related to a loss, understand how pregnancy loss can affect mental health, talk about pregnancy loss, facilitate a return to work and the importance of regular follow-ups and check-ins.
The speaker line-up includes performance coach and head of training at VDS training, Carolyne Crowe, Jamie Callan, Professor of Leadership & HRD and Director of Equity & Diversity at Newcastle Business School and Laura Whyte, who was HR Director at the John Lewis Partnership and is now a Non-Executive Director with a number of organisations including XLVets, the British Horseracing Authority and the Ministry of Defence.
A number of women from industry and practice will also share their experiences and perspectives in short sessions entitled ‘If you can see it, you can be it!’ to reflect how veterinary women can tackle challenges and make the most of opportunities.
The event is being steered by Liz Barton, the editor of Veterinary Woman, and Kerrie Hedley, the Chief Operating Officer at XLVets. Liz said: “We’ve been working hard to develop resources for women in the profession for the last few years and it’s wonderful to see so many women coming together and providing the skills and inspiration that will help other women aspire to leadership roles.”
Kerrie, who will be running a workshop on 'Overcoming Stereotypes: What does the future leader look like?' added: "From the research I undertook last year we know that there is a stereotypical perception of what a leader looks like in the profession, for example a requirement to work full time. This workshop is about crushing that stereotype and defining what the future leader could look like. I'm really excited to be supporting women to develop innovative solutions in their leadership journey and look forward to seeing what we can achieve at this inaugural event."
The event is open to anyone in the profession – vets, RVNs, practice managers, whether from independent or corporate practice, industry or academia. Registration costs £45, inclusive of VAT and £20 for students if booked at the early bird rate before 31st August.
Recordings will be available to anyone who registers but can’t attend the whole six hours.
Registration is now open at https://bit.ly/VeterinaryWomenInLeadership.
There will be 20 presentations from some of the world's leading experts, covering topics such as detection and diagnosis, advances in veterinary oncology, supportive care for the cancer patients, how to build a partnership with pet owners and, of course, feeding the cancer patient.
The presentations will be streamed live and available on demand afterwards, at https://learn.hillsvet.com/en_GB/hills-global-symposium-2023
Dr. Iveta Becvarova, Senior Director of Global Academic & Professional Affairs at Hill's Pet Nutrition said: "This year’s Hill’s Global Symposium will offer the latest advancements and innovations to help veterinary professionals support and counsel their clients, and provide the best care possible to the pets in their care."
On hand to answer your questions is Adam Gregory, RVN NCert (Anaesth) DMZAA DipVNZS APVN, Head Nurse at Great Western Exotics.
Before putting your questions to Adam, you're invited to read his article on the subject here: https://www.veterinary-practice.com/article/pain-management-in-the-avian-patient
Then join the Clinical Article Club here: https://www.vetnurse.co.uk/vetnurse-clinical-article-club and post your question or discussion point in the forum.
Remember, you can claim time spent reading or participating in the discussion towards your annual CPD requirement: press the 'Claim CPD' button at the top right of the discussion thread.
Spread over two floors, the 3,300 sq ft flagship practice is unusually large for a London clinic, and has a dedicated dental suite and laboratory, as well as six spacious and bright consulting rooms.
Notably absent from the practice are a reception desk and continuously ringing telephones.
Instead, customers receive a warm welcome in the members’ area, with separate spaces for cats and dogs.
Shades of lilac on the walls have been carefully chosen to keep animals calm, while a pick and mix wall filled with toys and treats helps pets to develop positive associations with vet visits.
Co-founders Russell Welsh MRCVS and online estate agent entrepreneur Daniel Attia say that a large portion of Creature Comforts’ customers have signed up as ‘All Access’ members, paying £20 per month to get unlimited access to expert care from vets and nurses.
This includes as many consultations as they need, annual vaccinations and discounted routine treatments e.g. 50% off microchipping.
The remainder have opted to pay as they go for treatment.
Creature Comforts’ chief veterinary officer, Dr Simon Hayes, says: “One of the biggest problems with UK veterinary care is that, due to the expense of consultations, pet owners are understandably reluctant to book in to see a vet until their animals are really sick.
"With a subscription model that includes unlimited consultations, we’ve removed the cost barriers to accessing expertise easily and quickly, so pets are seen more frequently, and conditions can be identified and treated earlier in the disease process, meaning a vastly better outcome for pets and hopefully greater financial savings over their lifetime, too.”
Simon added: “Many people comment on the peace and quiet.
"The absence of phones ringing or receptionists permanently on calls is unusual.
"But because our customers book in, submit queries and request medications via our app, we don’t need these things.
"While our virtual care team can take calls, they’re not based in the practice.
"This frees up our people to welcome customers and make a fuss of their pets so we can turn what has long been a stressful appointment into a positive experience.
"People have told us their pets, who trembled and cried at their previous vet, are now pulling to come inside because they know they’re going to get a treat and lots of attention.
"We’re still doing all the things vets do, in terms of offering excellent care, expertise and advice, but the entire experience around it has been totally transformed.”
Creature Comforts’ third site, also in London, will open towards the end of this year, and the company is keen to hear from veterinary surgeons, nurses and others who may be interested in upcoming vacancies.
Kit, or, to give him his full title, Dr Kit Sturgess MA, VetMB, PhD, CertVR, DSAM, CertVC, FRCVS, RCVS Recognised Specialist in Small Animal Medicine, has been working as an internist in private referral practice since 2003. In 2006 he became a founding partner in a multidisciplinary referral centre that he saw grow from five to 65 members of staff within five years.
He is also Chair of BSAVA Education Committee, Trustee of Cats Protection and Chair of Trustees of the Wildheart Trust. He was formerly an RCVS Knowledge Trustee and member of RCVS Council.
Kit has authored numerous articles and two textbooks, and presents lectures and research abstracts at conferences worldwide.
Kit will take up the editorship on 2nd September, succeeding Professor Peter Cockcroft. He said: “I am delighted to take on the editorship of Veterinary Evidence. With readers in 150 countries and output that has more than doubled over the past three years, the journal has quickly become a mainstay of evidence-based veterinary medicine, which is a testament to Peter’s enthusiasm and commitment to the development of the journal and its impact on the veterinary community.
"I am excited about leading Veterinary Evidence in its next stage of development, with recent events showing the critical importance of open online access. Veterinary Evidence is ideally placed to support an ever-growing and wide range of veterinary professionals by further developing a multimedia, multiplatform approach facilitating the use of evidence-based medicine in their daily practice."
Veterinary Evidence journal can be read at: veterinaryevidence.org
Otomicol contains miconazole nitrate, prednisolone acetate and polymyxin B.
The product targets a range of pathogens including miconazole and polymyxin B-sensitive, Malassezia and Pseudomonas spp.
Renzo Di Florio, technical vet at Krka UK, said: “With its multifactorial aetiology, ear disease is often challenging to manage, causing frustration for owners and significant discomfort for pets.
"Otomicol is a cost-effective solution that veterinary surgeons can add to their treatment toolbox for cases where bacterial and fungal infection are important factors.”
Otomicol ear drops and cutaneous suspension are available in a 15ml bottle with an extended shelf life of six months after opening.
Otomicol is available from veterinary wholesalers.
https://www.krka.co.uk
Reference
The new product is being sold through e-retailers including Pet Drugs Online, Animed and Pets at Home.
Frontpro is claimed to kill fleas within 8 hours and protect dogs from fleas and ticks for one month.
It is suitable for all breeds aged eight weeks or older (weighing two kilograms or more) and can be given with or without food.
A company spokesperson said: "Boehringer Ingelheim is committed to expanding access to high-quality parasite prevention for dogs, which is why we’re proud to introduce an effective new option.
"Frontpro chewable tablets provide effective protection from fleas and ticks, while complementing the regular care and advice pet owners receive from their veterinarians."
www.uk.frontline.com
The webinars are open to veterinary clinics across the UK and the US, including those not affiliated to Premier Vet Alliance.
The programme is as follows:
Jo Wells, Premier Vet Alliance’s Business Relationship Manager said: “We’ve concentrated on providing a blend of practical advice and insights, people management support and also some inspiring motivational ideas.
“Because we operate globally, we’ve engaged speakers from both sides of the Altlantic which presents insights into alternative ways of working and thinking. We’ve also kept the webinars to just an hour-long in length so they are time efficient.
“As well as providing what we hope will be valuable content, the webinars will also encourage a platform for networking and on-going communication.
To register for the first event on Thurday 24th February, visit: https://tinyl.io/5ZtP
Furosoral contains furosemide and is indicated for the treatment of hydrothorax, hydropericardium, ascites and oedema, particularly in animals where these conditions are associated with cardiac insufficiency and renal dysfunction.
Furosoral replaces Dechra’s previous diuretic treatment, Frusedale.
It is available in both 10 mg and 40 mg double-divisable tablets.
The recommended daily starting dose for cats and dogs is 2.5 mg per kg of body weight.
Dechra says careful weighing is essential to ensure accurate dosing, but that the dosage can be doubled initially for severe or particularly resistant cases and adjusted to the lowest clinically effective dose for maintenance therapy if required.
Dechra companion animal brand manager, Charlotte Hill, said: “Furosoral offers a flexible treatment solution where dosage can be adjusted, depending on the needs of the patient and the underlying causes, to give vets more options for treating cats and dogs with fluid retention.
“To ensure it is as appealing to pet owners as it is to veterinary professionals, Furosoral is available in our innovative Smart Tab format, giving owners confidence that they are giving their dog or cat the right dosage and aiding compliance, leading to better outcomes for the animal.”
Furosoral 10 mg and 40 mg tablets are available in blister packs of 100 tablets for quick and easy dispensing. Divided tablets can be stored in the blister pack for up to three days, ensuring no waste.
https://www.dechra.co.uk/products/dog/prescription#/search=furosoral/.
The double-blind placebo-controlled study will examine whether the pheromone collar can help reduce the severity or development of certain potentially problematic behaviours in puppies and it is open to puppies less than 12 weeks of age.
Puppies will have to wear a collar until they are six months of age and their owners will be asked to complete a check sheet relating to their puppy’s behaviour every month. Each month a new collar will be sent direct to their home.
To encourage enrolment, the University of Lincoln is offering veterinary professionals a £10 voucher for every successful sign up to the trial.
Owners who complete all questionnaires will receive a pack of canine health and welfare goodies from Ceva Animal Health. The pack will include Adaptil Junior, Adaptil Transport and Logic Oral Hygiene Gel.
Owners will also be entered into a draw to win an iPad.
A marketing pack is available to raise awareness of the study and includes a waiting room poster, owner leaflets and a social media post for Twitter, Facebook or Instagram.
For further information, email the University of Lincoln at puppydevelopment@lincoln.ac.uk.
Topics include applying the principles of antimicrobial stewardship (AMS), making confident diagnostic and prescribing decisions, and managing client expectations around antibiotic use within practice.
In the first episode, Tim explores how to apply the principles of AMS in the consulting room, starting with recognising when antibiotics are genuinely needed.
He explores the role of clinical signs and cytology in guiding diagnosis and treatment decisions, while also emphasising the risks of unnecessary prescribing.
The discussion also covers when empirical antibiotic use may be appropriate and how to ensure these decisions are justified.
Each episode offers practical, evidence-based insights which Krka says can be easily implemented in general practice.
The series is accompanied by downloadable Vet2Vet Insights information sheets that summarise the main take-home messages from each episode.
https://open.spotify.com/show/0uphORU03q29WncwmN2EIa
The information sheets are available here: https://www.krka.co.uk/veterinary-knowledge-hub/articles/responsible-use-of-companion-animal-antibiotics
Phovia, which was launched in the UK last year, is a two-part FLE system consisting of a chromophore gel that is applied to the affected skin and a blue light LED lamp.
Vetoquinol says that when used together they produce light of varying wavelengths that penetrates the skin to different depths, helping to control bacteria and reduce inflammation on the surface of the skin and stimulating regeneration in the epidermal and dermal layers.
The unit is portable, and applications take four minutes once a week.
The authors of the Vetoquinol-funded study say that FLE has already been shown to support and accelerate natural skin healing, but this latest research shows that the benefits go beyond improvement in clinical signs.
The study looked at 35 dogs with a diverse range of skin conditions: 13 had interdigital furunculosis, 10 had deep pyoderma, 6 had wounds, 4 had pyotraumatic dermatitis, and 2 had perianal fistula on presentation.
Eight of 35 dogs were new cases, whereas the remaining 27 were undergoing recrudescence of a prior episode, including pyotraumatic dermatitis, wounds, deep pyoderma, interdigital furunculosis and perianal fistulae.
Thirty dogs (86%) achieved a clinical resolution: 18 with the Fluorescent Light Energy alone and 12 with the concomitant use of FLE and topical antiseptic shampoo.
Five dogs (14%) had a partial response and needed other therapies.
92% percent of owners attested to their pet’s enhanced quality of life, with 74% of dogs displaying at least a 50% improvement in owner-reported behaviour, mood, sleep and playing activities.
The study also reported a 46% reduction in caregiver burden.
Felicity Caddick, Technical Services Manager at Vetoquinol said: “Managing skin conditions often requires the long-term use of shampoos or topical therapies.
"Many owners find this aspect of pet ownership challenging, especially with larger dogs, or less cooperative animals.
"FLE can reduce or in some cases eliminate the need for topical therapies at home, not only simplifying the treatment process but also enhancing convenience and compliance.
"Sharing responsibility for administering ongoing treatment with their vet practice also removes some of the worry associated with their pet’s health.”
Vetoquinol also highlights that Phovia can offer vets a drug-free management option for skin disorders that aligns with the principles of antibiotic stewardship.
The survey was held between the 1st and 5th May and was sent to the 3,139 UK veterinary practices for which the RCVS holds a unique email address. In total it gathered 251 responses (a response rate of 8%) compared to the 532 responses to the initial survey conducted between 3rd and 7th April (a response rate of 17%).
The main changes compared to last month's survey were:
Lizzie Lockett, RCVS CEO, said: "This latest survey has identified some positive trends in terms of a slight uptick in business, including turnover, and fewer incidences of staff having to take time off with COVID or COVID-like symptoms.
“I am glad to see that the framework we published in April has, so far as we can see, provided veterinary professionals with greater guidance and reassurance regarding the fact that if it is feasible to do something safely under social distancing guidelines, then they can go ahead, if they choose to.
"We left plenty of scope for veterinary professionals to use their clinical judgement as to what services actually offer, depending on their facilities, level of staffing, availability of protective equipment, local disease pressures and so on.
"However, it is also clear that we are, by no means, out of the woods and that veterinary businesses are still struggling financially, with some of them reporting a very acute impact of the coronavirus and the associated restrictions on their businesses.
“We will continue to monitor the situation via these regular surveys, with the next one planned for early June. I would urge as many practices as possible to continue to complete them, so that we can build up a stronger evidence-base on how veterinary businesses have been affected. This information is not only vital for our own policy decisions but also allows us to present a stronger case to the Government and other public bodies where we wish to influence the decisions they make that will impact the veterinary professions and businesses.”
The survey results can be read in full at www.rcvs.org.uk/coronavirus-resources.
Led by Aarti Kathrani, a senior lecturer in small animal internal medicine at the Royal Veterinary College, and Jennifer Larsen, Professor of Clinical Nutrition at the University of California School of Veterinary Medicine, the presentation will focus on how veterinary professionals in general practice can manage nutritional recommendations for patients that have two or more health conditions with competing or overlapping nutritional needs.
During the webinar, Aarti and Jennifer will share practical insights into making effective clinical decisions when selecting diets for patients with multiple conditions and reflect on how this can support the management of these cases.
They will explore scenarios where the optimal diet for one condition may not be suitable for a concurrent condition, requiring clinicians to prioritise.
The speakers will also address how nutrition and feeding management can be modified to ensure medication delivery without compromising therapeutic efficacy.
The webinar will also address the issue of pet owners seeking non-veterinary recommendations or relying on internet research for advice (something which apparently 78.6% of pet owners do1).
https://webapp.spotme.com/login/eventspace/CollaborativeCareJuly2023
The company says it has renamed the product to better reflect its main use, which is for maintaining skin and coat health in cats and dogs.
Chris Jones, Managing Director at Nutravet said: “We’re continually looking at ways to improve our product offering, which includes ensuring our product range can be discussed with ease between veterinary professionals and pet owners.
"Nutracoat has been used in international markets since launch, and we now feel that the natural progression is to mirror transition the use of Nutramega to Nutracoat in the UK."
www.nutravet.com
The initiative was launched by the RCVS and the BVNA in 2016 to identify and find solutions to some of the specific issues facing the veterinary nursing profession.
In July 2016 it published the VN Futures Report and Action Plan which set out 31 actions under six broad strategic aims.
To follow up these actions, six working groups were formed to look at the broad strategic areas and, in June 2018, it was decided to set up a VN Futures Board to help coordinate and oversee the work of these groups. The Board comprises the RCVS Veterinary Nurses Council Chair and Vice-Chair, Racheal Marshall and Liz Cox, and the BVNA President and Vice-President, Wendy Nevins and Jo Hinde.
Outgoing Chair Wendy Nevins said: "In its first 12 months, the VNF Board has really got to grips with the direction and legacy of the VN Futures initiative. The clarity and direction it has brought is reinvigorating the Working Groups. The next 12 months will see a real focus on delivery of the original findings of the VFN Futures initiative."
The VNF initiative is nearly three years into its original five-year life span and the Board reported that progress thus far has included the development of two new Diplomas in Advanced Veterinary Nursing, more resources to help both VNs and vets navigate Schedule 3 and publication of career case studies to demonstrate the diverse roles available in the profession.
Wendy added: "The VN Futures project has a fixed five-year horizon to make sure we keep focus on what the profession said it wanted – and needed – to be delivered. At the end it will be for the profession to decide how well this has been done – and what comes next."
The Board also confirmed plans to have a presence at the Royal Veterinary College’s Student Veterinary Nurse Fest this summer, as well as events at the BVNA Congress in October and the British Small Animal Veterinary Association Congress in April 2020.
Racheal Marshall said: "The energy and life of the VN Futures initiative comes from veterinary nurses so we are excited to be taking this back out to meet nurses and ask them for their thoughts and comments on how these issues – like career progression, further qualifications, and emerging agendas like One Health – matter to them. We are really looking forward to a busy program of congress events in order to hear from people!"
To download the VN Futures Report and Action Plan and view some of the initiative’s latest blogs, case studies and other online resources, visit: www.vetfutures.org.uk/vnfutures/
The new Veterinary HPM Adult Neutered Wet with Salmon (a lifestage diet) and Urology Cat Wet (a clinical diet) have a high-protein low-carbohydrate formulation and a high share of animal protein.
Virbac points to studies which show that FLUTD is diagnosed in 8% of cats seen by vets for non-routine appointments1 and that there is a 51% risk of recurrence within one year of the initial diagnosis2.
Dr Rémi Mandray DMV MRCVS, Product Manager at Virbac, said: "Feline specialists recognise the importance of nutrition and water intake in the management of FLUTD, so we are delighted to be able to add two high quality wet diets to the Veterinary HPM range and therefore offer advanced nutritional solutions to such an important health issue."
Virbac says that both diets have high levels of animal protein to stimulate water intake, increase the volume of urine and stabilise the pH for a healthy urinary system.
The lifestage diets include supplements to limit phosphorus excretion in the urine for improved prevention of struvite crystal formation.
The company also says the Urology diets in the clinical range meet the PARNUT requirements for dissolution and prevention of struvite stones or crystals, and prevention of oxalate formation.
Virbac claims the new chunks in gravy wet diets naturally increase water intake by up to 50%, due to their high water content.
Dry and wets can be fed together as part of a mixed nutritional programme, to meet pet owner preferences identified in Virbac's market research: 60% of cat owners use wet food, mostly mixed with kibbles4.
For more information, contact your Virbac Territory Manager.
References
Season 2 has been launched after a staggering 50,000 people completed the first series, which was launched in 2018.
Ceva says the benefits of completing the course, beyond it counting towards your annual CPD requirement, include:
Season 2 is available on demand at: https://gbr.ceva.vet/index
For the study, researchers from the RVC, University of Edinburgh and Scotland’s Rural College analysed data from the RVC’s VetCompass Programme on a random sample of 2,440 nail clipping cases taken from over 2 million dogs under UK primary veterinary practice care during 2019, 5.64% of UK dogs (over one in twenty dogs) were found to have had their nails clipped at least once as part of their primary veterinary care each year.
The nail clipping was the primary reason for attending the veterinary visit for more than half (59.40%) of those dogs.
The most cited clinical reasons for nail clipping veterinary visits were overgrown and/or ingrown nails (12.66%) and broken claws or dewclaws (8.84%).
Of the breeds that were most likely to present for nail-clipping, 13.29% of chihuahuas were clipped each year, 12.58% of beagles, 11.98% of greyhounds and 9.36% of pugs.
Dog breeds with a skull shape that deviated from a typical medium-length skull in either direction also had a higher risk of needing nail clipping.
Flat-faced dogs breeds (e.g. pugs, French bulldogs, shih tzus) were 1.67 times more likely to have their nails clipped, while breeds with long faces (e.g. greyhound, whippet) were 1.32 times more likely to have their nails clipped, compared to breeds with a medium length skull (e.g. Labrador retriever, English springer spaniel).
Dog breeds with shortened and often twisted legs (chondrodystrophic breeds) were also 1.44 times more likely to have their nails clipped compared to dog breeds with straight legs.
Age and body weight also affected a dog’s chances of undergoing nail clipping.
Young dogs aged between 1 to 2 years were the most likely to have nail clipping procedures.
Smaller dogs weighing less than 10.00 kg had higher odds of overgrown nails compared to larger dogs weighing 40.00 kg or more.
The researchers say that frequency of nail clipping in primary veterinary care indicates the need for comprehensive teaching of canine nail care in veterinary and veterinary nursing education, as well as proactive veterinary monitoring, nail care protocols and owner education.
Dr Dan O’Neill, Associate Professor of Companion Animal Epidemiology at the RVC and co-author of the paper, said: “This new VetCompass study shows that some dog breeds have more than twice the need to have their nails clipped compared to other breeds.
"This highlights just how distinct humanity has made each dog breed and suggests we are getting close to the time when we should no longer consider all dog breeds as even being the same species.”
Dr Lavin Ahmed, Veterinary Surgeon, President of Protecting Animals in Kurdistan Organization (PAKO) and lead author of the study, said: “When I was first offered nail clipping by RVC VetCompass as my MSc research topic, I honestly underestimated its significance.
"It seemed like just another routine procedure that we all do every day in veterinary practice.
"However, reading the clinical records made it clear that nail care is more than just a trivial grooming procedure but is a genuine welfare issue that deserves much more attention in both veterinary training and owner education.”
Some 150 practices currently use Vidivet, which was set up by Ben Sweeney MRCVS (pictured) in 2020.
He said: “I started VidiVet as I wanted people to be able to access high quality, impartial care for their pets that allows them to make more informed decisions around their treatment with expert information, rather than resorting to the internet.
"As a vet I also wanted to make life easier for those working within veterinary practices.
"VidiVet relieves part of the burden veterinary practices face by offering a trusted digital triage service for their clients.
"Our digital service can provide a helpful extension to a practice which dramatically reduces admin and saves time for the in-house team.
"Crucially, we offer peace of mind and reduce anxiety for pet owners, and with over 96% of VidiVet out of hours calls redirected to the pet owner’s registered vet, it can really enhance the practice bond by using digital care to augment physical care."
Before the Provet partnership, OOH case notes were sent to client practices which then had to enter them onto their systems manually.
Vidivet says the intregration with Provet means less admin and time savings for practices and a quicker follow up for pet owners.
https://vidivet.com
https://www.provet.cloud
The course will cover reptiles, pet mammals and captive birds.
Marie says the course will teach you how to approach exotic emergencies confidently, from clinical examination and forming differential diagnoses to medical and surgical approaches for common emergency presentations.
Marie will discuss both clinical management and the stabilisation and care of the critical patient, including fluid therapy, analgesia, contra-indicated medications and hospital cage requirements.
Welfare-focused euthanasia approaches will also be covered for different species.
Tickets cost £300 and the course is open to veterinary surgeons, veterinary nurses and students on a recognised veterinary or nursing course.
Lunch, tea, coffee and biscuits included.
https://evolutionexoticsreferrals.co.uk/cpd-booking-form/
The company’s NEMO Cardiac Health Screening test detects heart disease using AI to analyse microRNAs - biomarkers that manage the immune system and its responses and act as regulators for disease progression or resolution.
MI:RNA says the new test, which can be taken from blood or urine samples, will help vets diagnose and monitor disease progression more effectively and give cats and dogs with heart disease 18 months more life.
Eve Hanks, CEO and founder of MI:RNA (pictured) said: “The use of precision medicine in veterinary diagnostics will help pet owners and breeders alike to ascertain where to direct their efforts and finances accordingly.
"There is massive potential to use this technology to help breeds who have real problems with heart and other diseases, and will consequently help owners and breeders to identify affected animals more quickly.
Professor Joanna Dukes-McEwan, Head of the Cardiology Service at the University of Liverpool said: "From our cardiac investigations, we knew exactly the underlying heart disease and the severity of this, so our data was used as a training set for the MI:RNA panel analysis.
"We have previously collected samples from dogs with myxomatous mitral valve disease and are currently collecting samples from cats with hypertrophic cardiomyopathy.
“I think the MI:RNA panels are most useful for vets in primary care practice to identify and confirm the severity of underlying cardiac disease in their patients.
"A simple blood test which could confirm that the cause of a heart murmur is MVD, and also indicate its severity, and whether the patient would benefit from treatment would be really helpful for primary care vets in practice.
"They might indicate which patients may benefit from referral, or indicate when a specific treatment is indicated.
"Future research with miRNA panels may also indicate novel pathways in progression of disease which might increase our understanding of the disease, or novel therapeutic options.”
This, say the authors, could lead to shorter hospitalisation time and less stress for donor cats.
For the study, researchers at the Royal Veterinary College measured the systolic blood pressure of 100 client-owned cats which had been randomly assigned to receive IVFT or no fluid after blood donation.
Owners were also contacted following donation to record any changes in their cat.
The results showed no significant difference in blood pressure between cats that received post-donation IVFT and those that didn't.
The main reported changes were minor bruising at the venepuncture site and mild lethargy, with no significant difference between the IVFT and no-IVFT groups.
These findings suggest that IVFT post-blood donation may not be necessary, as haemodynamic stability appears to be maintained despite the loss of blood.
Dr Guedra Allais, lead author of the study, said: "Our study showed no significant difference in blood pressure at different time points in feline donors that received intravenous fluid compared to others that didn’t receive any fluid.
"Other perfusion parameters such as capillary refill time, heart rate and pulse quality were not evaluated, and we recommend considering intravenous fluid in any feline donors if any major changes are detected on post donation physical examination.”